Ajay Gupta
Principal investigator, leads CELESTIAL THERAPEUTICS INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$2.2MFederal grants as PI4 awards
1Patents grantedLatest Oct 6, 2026
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 30, 2026 | NIH | SBIR Phase II Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $643K | CELESTIAL THERAPEUTICS INC |
| Jul 30, 2025 | NIH | SBIR Phase II Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $1.0M | CELESTIAL THERAPEUTICS INC |
| Apr 11, 2023 | NIH | SBIR Phase I Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $290K | CELESTIAL THERAPEUTICS INC |
| Apr 11, 2023 | NIH | SBIR Phase II Development of a dry powder inhalation product against Respiratory Syncytial Virus based on an endogenous anionic pulmonary surfactant lipid | $290K | CELESTIAL THERAPEUTICS INC |
2 patents as inventor
- US 12751920CELESTIAL THERAPEUTICS INCOct 6, 2026
- US CELESTIAL THERAPEUTICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#896
Awards as PI#566
Patents#155
Companies
- CELESTIAL THERAPEUTICS INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.